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background: Duchenne and Becker muscular dystrophy (DBMD) are caused by mutations in dystrophin. Cardiac manifestations vary broadly 
across the population, making prognosis difficult. Current dystrophin genotype-cardiac phenotype correlations are limited.
Methods: A direct translational model was applied to patient-specific deletion, indel, and point mutations to predict exons and protein domains 
expected to be present in truncated dystrophin protein. The predicted presence of exons 45, 48-49, and 51-52, and the actin-binding, rod, hinge-III, 
cysteine-rich, and C-terminal domains were correlated with the development of myocardial fibrosis (represented by late gadolinium enhancement 
(LGE)) and left ventricular (LV) dysfunction on cardiac MRI via risk (chi-square) and survival (Kaplan Meier log rank) analysis.
results: The predicted presence of exons 45, 48-49, and 51-52, and the actin-binding, rod, and hinge-III domains did not show a relationship 
to the risk of, age of onset of, or freedom from LGE and LV dysfunction for 274 DBMD patients. Those with predicted presence of the cysteine-rich 
(n=34) and C-terminal (n=30) domains showed lower risk of LGE (RR 0.40, p=0.011 and RR 0.37, p=0.012 respectively) and trended toward 
prolonged freedom from LGE (p=0.060 and 0.054). Those with predicted presence of the C-terminal domain also trended toward lower risk of LV 
dysfunction (RR 0.21, p=0.060) and prolonged freedom from LV dysfunction (p=0.090). Only patients with in-frame deletions were predicted to have 
an intact C-terminal domain.
conclusions: Genotypes previously shown to correlate with altered cardiac phenotype in DBMD patients were not significantly related to the 
development of LGE and LV dysfunction. Patients predicted to have intact cysteine-rich and C-terminal domains trended toward a less severe cardiac 
phenotype, and these patients had in-frame deletions. The reading-frame rule, which suggests that DBMD patients with in-frame deletions have 
milder skeletal muscle disease, may be applicable for the cardiac phenotype as well. Genotype-phenotype correlations may help predict the cardiac 
phenotype for DBMD patients and guide which patients may benefit from future therapies.
